Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive
18F-YJH08, a novel radioligand targeting the glucocorticoid receptor to understand the pathobiology of cancer and major depressive disease.
Michael Evans, Yangjie Huang, Ning Zhao, Yung-Hua Wang, Youngho Seo, David Wilson, Joseph Blecha, Henry VanBrocklin and Spencer Behr
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 261;
Michael Evans
1Radiology and Biomedical Imaging UCSF San Francisco CA United States
Yangjie Huang
1Radiology and Biomedical Imaging UCSF San Francisco CA United States
Ning Zhao
1Radiology and Biomedical Imaging UCSF San Francisco CA United States
Yung-Hua Wang
2UCSF San Francisco CA United States
Youngho Seo
3University of California, San Francisco San Francisco CA United States
David Wilson
1Radiology and Biomedical Imaging UCSF San Francisco CA United States
Joseph Blecha
2UCSF San Francisco CA United States
Henry VanBrocklin
4University of California San Francisco San Francisco CA United States
Spencer Behr
5University of California - San Francisco San Francisco CA United States
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
18F-YJH08, a novel radioligand targeting the glucocorticoid receptor to understand the pathobiology of cancer and major depressive disease.
Michael Evans, Yangjie Huang, Ning Zhao, Yung-Hua Wang, Youngho Seo, David Wilson, Joseph Blecha, Henry VanBrocklin, Spencer Behr
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 261;
18F-YJH08, a novel radioligand targeting the glucocorticoid receptor to understand the pathobiology of cancer and major depressive disease.
Michael Evans, Yangjie Huang, Ning Zhao, Yung-Hua Wang, Youngho Seo, David Wilson, Joseph Blecha, Henry VanBrocklin, Spencer Behr
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 261;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.